Sensitivity To Novel Tyrosine Kinase Inhibitors of Highly Resistant Single and Polymutant Bcr-abl1: A Combined Approach
•
D. Gibbons
•
altro
A. Quintas Cardama
2012
Periodico
ANNALS OF ONCOLOGY
Abstract
In this paper we discuss the results of the coupled in silico/experimental approach to the resistance phenomena in cancer targeted therapy of tyrosin kinase mutations.
DOI
WOS
Archivio
Diritti
metadata only access
Soggetti